Citation: Elamin H. Elbasha. Model for hepatitis C virus transmissions[J]. Mathematical Biosciences and Engineering, 2013, 10(4): 1045-1065. doi: 10.3934/mbe.2013.10.1045
| [1] | N. Engl. J. Med., 327 (1992), 1899-1905. |
| [2] | Clin. Infect. Dis., 46 (2008), 1852-1858. |
| [3] | J. Gastroenterol. Hepatol., 15 (2000), E105-E110. |
| [4] | Oxford University Press, Oxford, 1991. |
| [5] | Ann. Intern. Med., 144 (2006), 705-714. |
| [6] | Arch. Intern. Med., 167 (2007), 166-173. |
| [7] | J. Gastroenterol. Hepatol., 25 (2010), 1276-1280. |
| [8] | Ann. Intern. Med., 127 (1997), 55-65. |
| [9] | Int. Stat. Rev., 62 (1994), 229-243. |
| [10] | in "Quantitative Evaluation of HIV Prevention Programs" (Eds. Brookmeyer Kaplan ), (2002), 260-289. Yale University Press, New Haven. |
| [11] | Gut, 56 (2007), 385-389. |
| [12] | MMWR Recomm Rep., 47 (1998), 1-39. |
| [13] | 2010. (accessed October 5, 2012), http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm\#section1. |
| [14] | Recommendations and Reports, 61 (2012), 1-18. |
| [15] | Hepatology, 39 (2004), 74-80. |
| [16] | Hepatology, 31 (2000), 1014-1018. |
| [17] | J. Biol. Sys., 13 (2005), 331-339. |
| [18] | J. Math. Biol., 28 (1990), 365-382 . |
| [19] | J. R. Soc. Interface, 7 (2010), 873-885. |
| [20] | Nat. Biotechnology, 27 (2009), 305-306. |
| [21] | J. Infect. Dis., 198 (2008), 1651-1655. |
| [22] | Bull. Math. Biol., 70 (2008), 894-909. |
| [23] | Antivir Ther., 16 (2011), 1187-1201. |
| [24] | Hepatology, 49 (2009), 1335-1374. |
| [25] | Hepatology, 44 (2006), 1139-1145. |
| [26] | SIAM Rev., 42 (2000), 599-653. |
| [27] | Am. J. Gastroenterol, 103 (2008), 1283-1297. |
| [28] | 3rd edn. Prentice Hall, New York, 2002. |
| [29] | BMJ, 341 (2010), c3374. |
| [30] | Proc. Roy. Soc. Lond. A., 115 (1927), 700-721. |
| [31] | Transfusion, 49 (2009), 2454-2489. |
| [32] | in "Hepatitis C and Injecting Drug Use: Impact, Costs and Policy Options" (eds. J. C. Jager, W. Limburg, M. Kretzschmar, M. J. Postma and L. Wiessing), Lisbon: European Monitoring Centre For Drugs And Drug Addiction, (2004). |
| [33] | J. Virol., 76 (2002), 6586-6595. |
| [34] | J. Theor. Biol., 254 (2008), 178-196. |
| [35] | Math. Biosci., 182 (2003), 1-25. |
| [36] | J. Viral. Hepat., 15 (2008), 399-408. |
| [37] | J. Community Health, 33 (2008), 126-133. |
| [38] | Proc. Roy. Soc. Lond. B., 253 (1993), 9-13. |
| [39] | Lancet., 359 (2002), 1478-1483. |
| [40] | Science, 282 (1998), 103-107. |
| [41] | N. Engl. J. Med., 330 (1994), 744-750. |
| [42] | Gastroenterology, 138 (2010), 315-324. |
| [43] | Infec. Gene. Evol., 5 (2005), 131-139. |
| [44] | Crit. Rev. Immunol., 30 (2010), 131-148. |
| [45] | Math Biosci. Eng., 1 (2004), 81-93. |
| [46] | Nat. Med., 6 (2000), 578-582. |
| [47] | Math. Biosci., 180 (2002), 29-48. |
| [48] | Hepatology, 50 (2009), 1750-1755. |
| [49] | Transfusion, 42 (2002), 537-548. |
| [50] | http://www.who.int/mediacentre/factsheets/fs164/en/index.html (accessed October 29, 2012). |
| [51] | Drug Alcohol. Depend., 110 (2010), 228-233. |